Pawel Zebrowski
Overview
Explore the profile of Pawel Zebrowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Golenia A, Olejnik P, Maciejewska O, Wojtaszek E, Zebrowski P, Malyszko J
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458033
Chronic kidney disease (CKD) is a risk factor for cognitive impairment (CI), and this risk is the highest in patients with end-stage kidney disease (ESKD). As a multifactorial disease, CI...
2.
Golenia A, Olejnik P, Grusiecka-Stanczyk M, Zolek N, Wojtaszek E, Zebrowski P, et al.
Brain Behav
. 2024 Aug;
14(8):e3647.
PMID: 39135287
Introduction: Cognitive impairment (CI) is common in both end-stage kidney disease (ESKD) and alcohol-related liver cirrhosis. The aim of this study was to assess the prevalence and patterns of CI...
3.
Jakubowska Z, Kepska-Dzilinska M, Zebrowski P, Macech M, Nazarewski S, Galazka Z, et al.
Transplant Proc
. 2024 May;
56(4):992-994.
PMID: 38705736
Background: The risk of morbidity and mortality in the group of people qualified for kidney transplantation is high. Although currently, the qualification for kidney transplantation is very extensive and detailed,...
4.
Olejnik P, Golenia A, Maciejewska O, Wojtaszek E, Zebrowski P, Malyszko J
Ren Fail
. 2024 Jan;
46(1):2306232.
PMID: 38275184
Aim Of The Study: The study aimed to assess the prevalence of executive function impairment among patients with chronic kidney disease (CKD) undergoing dialysis, with no subjective cognitive problems and...
5.
Golenia A, Zolek N, Olejnik P, Zebrowski P, Malyszko J
J Clin Med
. 2023 May;
12(9).
PMID: 37176560
Introduction: Hemodialysis patients are at higher risk of developing cognitive impairment, but the pattern of affected cognitive domains is still undetermined. Little is also known about the symptoms of depression...
6.
Zawierucha J, Marcinkowski W, Prystacki T, Malyszko J, Pyrza M, Zebrowski P, et al.
Kidney Blood Press Res
. 2023 May;
48(1):385-391.
PMID: 37166319
Background: Hemodialysis is one of the most resources consuming medical intervention. Due to its concept, the proper amount of dialysis fluid passed through dialyzer is crucial to obtain the expected...
7.
Koscielska M, Matuszkiewicz-Rowiska J, Giercuszkiewicz D, Krawczyk M, Niewiski G, Sierdzinskid J, et al.
Transplant Proc
. 2022 Oct;
54(8):2397-2398.
PMID: 36272834
No abstract available.
8.
Koscielska M, Matuszkiewicz-Rowinska J, Giercuszkiewicz D, Krawczyk M, Niewinski G, Sierdzinski J, et al.
Transplant Proc
. 2022 Oct;
55(7):1765-1766.
PMID: 36202671
No abstract available.
9.
Marcinkowski W, Zuzda K, Zawierucha J, Prystacki T, Zebrowski P, Malyszko J, et al.
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146642
Patients with end-stage kidney disease undergoing hemodialysis are particularly vulnerable to severe COVID-19 as a result of older age and multimorbidities. Data are still limited and there are no published...
10.
Kendzia D, Lima F, Zawierucha J, Busink E, Apel C, Malyszko J, et al.
J Clin Med
. 2022 Jul;
11(14).
PMID: 35887931
Introduction: Home dialysis in Poland is restricted to the peritoneal dialysis (PD) modality, with the majority of dialysis patients treated using in-centre haemodialysis (ICHD). Home haemodialysis (HHD) is an additional...